The estimated Net Worth of Daniel R Glickman is at least $4.27 Миллион dollars as of 6 June 2024. Mr. Glickman owns over 650 units of CME Inc stock worth over $3,062,009 and over the last 22 years he sold CME stock worth over $930,979. In addition, he makes $279,182 as Lead Independent Director at CME Inc.
Daniel has made over 7 trades of the CME Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he sold 650 units of CME stock worth $130,936 on 6 June 2024.
The largest trade he's ever made was selling 900 units of CME Inc stock on 17 August 2020 worth over $155,898. On average, Daniel trades about 129 units every 65 days since 2002. As of 6 June 2024 he still owns at least 14,008 units of CME Inc stock.
You can see the complete history of Mr. Glickman stock trades at the bottom of the page.
Daniel Robert Glickman serves as Lead Independent Director of the Company. Mr. Glickman has served as Executive Director of the Aspen Institute’s Congressional Program since 2011 and as Vice President of the Aspen Institute since 2012. Mr. Glickman also has served as Senior Fellow for the Bipartisan Policy Center since 2010. From 2004 to 2010, Mr. Glickman served as Chairman and CEO of the Motion Picture Association of America, Inc. Mr. Glickman previously served as Director of the Institute of Politics at Harvard University’s John F. Kennedy School of Government from 2002 to 2004 and served as Senior Advisor in the law firm of Akin, Gump, Strauss, Hauer & Feld, from 2001 to 2004. He also served as U.S. Secretary of Agriculture from 1995 through 2001 and as a member of the U.S. Congress, representing a district in Kansas, from 1977 through 1995. Mr. Glickman is a Distinguished Fellow of the Chicago Council of Global Affairs and current member and Founding Chairman of the Board of the Foundation for Food and Agriculture Research, established in the 2014 Farm Bill by Congress, and Chairman of the International Advisory Board of APCO Worldwide, a public relations firm based in Washington, DC. Mr. Glickman also serves on a number of non-profit advisory boards with a focus on agriculture, food supply and food security. Mr. Glickman also co-chairs the company’s agricultural markets advisory committee.
As the Lead Independent Director of CME Inc, the total compensation of Daniel Glickman at CME Inc is $279,182. There are 12 executives at CME Inc getting paid more, with Terrence Duffy having the highest compensation of $11,867,200.
Daniel Glickman is 75, he's been the Lead Independent Director of CME Inc since 2014. There are 2 older and 39 younger executives at CME Inc. The oldest executive at CME Group Inc is Dennis Suskind, 77, who is the Independent Director.
Over the last 21 years, insiders at CME Inc have traded over $264,111,034 worth of CME Inc stock and bought 77,667 units worth $15,169,350 . The most active insiders traders include Terrence A Duffy, Phupinder Gill и Bryan T Durkin. On average, CME Inc executives and independent directors trade stock every 10 days with the average trade being worth of $863,868. The most recent stock trade was executed by Bryan T Durkin on 30 August 2024, trading 7,593 units of CME stock currently worth $1,629,382.
as the world's leading and most diverse derivatives marketplace, cme group (www.cmegroup.com) is where the world comes to manage risk. cme group exchanges offer the widest range of global benchmark products across all major asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather and real estate. cme group brings buyers and sellers together through its cme globex® electronic trading platform and its trading facilities in new york and chicago. cme group also operates cme clearing, one of the world’s leading central counterparty clearing provider in the world, which offers clearing and settlement services for exchange-traded contracts, as well as for over-the-counter derivatives transactions through cme clearport®. these products and services ensure that businesses everywhere can substantially mitigate counterparty credit risk in both listed and over-the-counter derivatives markets.
CME Inc executives and other stock owners filed with the SEC include: